Cargando...
Management of acquired resistance to EGFR kinase inhibitors in advanced NSCLC
The widespread adoption of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) for the first-line treatment of advanced EGFR-mutated non-small cell lung cancer (NSCLC) has resulted in acquired TKI resistance becoming a ubiquitous clinical problem. The identification of specific...
Gardado en:
| Main Authors: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2014
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4117471/ https://ncbi.nlm.nih.gov/pubmed/24752335 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.28723 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|